These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7007222)

  • 1. Anti-cancer action of retinoids.
    Medawar PB; Hunt R
    Immunology; 1981 Feb; 42(2):349-53. PubMed ID: 7007222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orchidectomy and immune response.
    Castro JE
    Ann R Coll Surg Engl; 1976 Sep; 58(5):359-67. PubMed ID: 788619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine prevents the immunosuppression induced in mice by anti-lymphocytic antiserum.
    Rosso di San Secondo VE; Fitch C; Aniasi A; Close FT; Sirchia G; Freeman ME
    Transplant Proc; 1996 Dec; 28(6):3193-5. PubMed ID: 8962238
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of 6-mercaptopurine-rabbit-anti-mouse lymphocyte globulin on the survival of skin allografts in mice.
    Hilgert I; Malberg K; Matthes K; Ambrosius H
    Folia Biol (Praha); 1982; 28(1):22-7. PubMed ID: 7040118
    [No Abstract]   [Full Text] [Related]  

  • 5. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 6. Histologic studies of lymphoid tissues in mice treated with immunosuppressive agents to prolong skin allografts.
    Arakawa M
    Nihon Geka Hokan; 1968 Sep; 37(5):608-22. PubMed ID: 4884280
    [No Abstract]   [Full Text] [Related]  

  • 7. Asialo GM1 positive CD8+ T cells induce skin allograft rejection in the absence of the secondary lymphoid organs.
    Yamanokuchi S; Ikai I; Nishitai R; Matsushita T; Sugimoto S; Shiotani T; Yamaoka Y
    J Surg Res; 2005 Nov; 129(1):57-63. PubMed ID: 16140338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of immunosuppressive drug and intrathymic inoculation of donor cells in skin graft survival.
    Dono K; Wood ML; Ozato H; Monaco AP
    Transplant Proc; 1994 Oct; 26(5):3061. PubMed ID: 7940963
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor bone marrow cell-treated mice.
    De Fazio SR; Plowey J; Hartner WC; Gozzo JJ
    Transplant Proc; 1994 Dec; 26(6):3102-3. PubMed ID: 7998084
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement by retinyl acetate of hormone-induced mammary tumorigenesis in female GR/A mice.
    Welsch CW; Goodrich-Smith M; Brown CK; Crowe N
    J Natl Cancer Inst; 1981 Oct; 67(4):935-8. PubMed ID: 6944559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connection between the anti-organ and anti-nuclear titres of antilymphocyte sera and their inhibitory effect on skin graft rejection in mice.
    Fekete B; Petrányi G; Szegedi G; Szabó G
    Haematologia (Budap); 1971; 5(4):419-23. PubMed ID: 4948255
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced allograft survival in rhesus monkeys treated with anti-human thymocyte globulin and donor lymphoid cells.
    Thomas JM; Carver FM; Burnett CM; Thomas FT
    Transplant Proc; 1981 Mar; 13(1 Pt 1):599-602. PubMed ID: 7022896
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of cross-species sensitization between skin allo- and xenotransplants in mice.
    Vizler C; Jánossy T; Tabi Z; Végh P
    Transplant Proc; 1994 Jun; 26(3):1324-5. PubMed ID: 8029925
    [No Abstract]   [Full Text] [Related]  

  • 15. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U; Choksi S; Marcucci L; Korngold R
    J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 17. Specificity requirement of donor bone marrow cells that prolong allograft survival: implications for a veto cell mechanism of action.
    De Fazio SR; Markees TG; Hartner WC; Gozzo JJ
    Transplant Proc; 1995 Feb; 27(1):171-3. PubMed ID: 7878960
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of immune unresponsiveness by intrathymic injection of allogeneic cells in a murine model.
    Sherburne CG; Onyekaba CO; Condie RM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):307-11. PubMed ID: 8438313
    [No Abstract]   [Full Text] [Related]  

  • 19. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
    Lima RS; Nogueira-Martins MF; Silva HT; Pestana JO; Bueno V
    Transplant Proc; 2004 May; 36(4):1015-7. PubMed ID: 15194353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.